1. Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study
   Avner Ehrlich et al, 2023, eLife CrossRef
2. Butyrate and Metformin Affect Energy Metabolism Independently of the Metabolic Phenotype in the Tumor Therapy Model
   Felix B. Meyer et al, 2021, Biomolecules CrossRef
3. Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity
   Hany S. Ibrahim et al, 2021, International Journal of Molecular Sciences CrossRef
4. Metformin alters therapeutic effects in the BALB/c tumor therapy model
   Felix B. Meyer et al, 2021, BMC Cancer CrossRef
5. The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
   Zhimin Tang et al, 2021, Anti-Cancer Agents in Medicinal Chemistry CrossRef
6. The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
   Chang Liu et al, 2021, Frontiers in Oncology CrossRef
7. Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China
   Jinqing Wu et al, 2021, Gastroenterology Research and Practice CrossRef
8. Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
   Hanjiao Qin et al, 2023, Frontiers in Pharmacology CrossRef
9. Loss of FBP1 by aPKC-ι/Snail Pathway-Mediated Repression Promotes Invasion and Aerobic Glycolysis of Intrahepatic Cholangiocarcinoma
   Meng Gao et al, 2021, Frontiers in Oncology CrossRef
10. Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
    Chin-Hsiao Tseng, 2020, Frontiers in Oncology CrossRef
11. Apoptotic and anti‐Warburg effect of Morusin via ROS mediated inhibition of FOXM1/c‐Myc signaling in prostate cancer cells
    Ja Il Koo et al, 2023, Phytotherapy Research CrossRef